A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection
PHASE2CompletedINTERVENTIONAL
Enrollment
316
Participants
Timeline
Start Date
August 31, 2012
Primary Completion Date
June 30, 2014
Study Completion Date
February 28, 2015
Conditions
Hepatitis C, Chronic
Interventions
DRUG
ABT-450/r
Tablet; ABT-450; Capsule; ritonavir
DRUG
ABT-267
Tablet
DRUG
Ribavirin (RBV)
Tablet
All Listed Sponsors
lead
AbbVie (prior sponsor, Abbott)
INDUSTRY
NCT01685203 - A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection | Biotech Hunter | Biotech Hunter